Log in to save to my catalogue

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in...

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520403

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

About this item

Full title

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e581-e581

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Extensive interindividual variation in response to chemotherapy is a major stumbling block in achieving desirable efficacy in the treatment of cancers, including multiple myeloma (MM). In this study, our goal was to develop a gene expression signature that predicts response specific to proteasome inhibitor (PI) treatment in MM. Using a well-charact...

Alternative Titles

Full title

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520403

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5520403

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/bcj.2017.56

How to access this item